Altered Plasma Fatty Acids Associate with Gut Microbial Composition in Common Variable Immunodeficiency

[1]  F. Visioli,et al.  Fatty Acids and Cardiovascular Risk. Evidence, Lack of Evidence, and Diligence , 2020, Nutrients.

[2]  N. Merendino,et al.  Polyunsaturated Fatty Acids and Microbiota Relationship: Implications in Cancer Onset and Treatment , 2020, Journal of clinical medicine.

[3]  M. L. Motti,et al.  ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer , 2020, Nutrients.

[4]  F. Song,et al.  Omega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials , 2020, British Journal of Cancer.

[5]  S. Pierzynowski,et al.  Absorption of Polyunsaturated Fatty Acid (PUFA) Is Related to IgG Blood Levels of Neonatal Pigs during the First 48 Hours Postpartum , 2020, Journal of immunology research.

[6]  F. Hu,et al.  Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies. , 2020, The American journal of clinical nutrition.

[7]  A. Kurilshikov,et al.  Impact of commonly used drugs on the composition and metabolic function of the gut microbiota , 2020, Nature Communications.

[8]  M. Wolters,et al.  Dietary fat, the gut microbiota, and metabolic health - A systematic review conducted within the MyNewGut project. , 2019, Clinical nutrition.

[9]  R. Caesar,et al.  Dietary lipids, gut microbiota and lipid metabolism , 2019, Reviews in Endocrine and Metabolic Disorders.

[10]  M. Johansson,et al.  Effects of Omega-3 Fatty Acids on Immune Cells , 2019, International journal of molecular sciences.

[11]  T. Kinoshita,et al.  Association between blood omega-3 polyunsaturated fatty acids and the gut microbiota among breast cancer survivors. , 2019, Beneficial microbes.

[12]  B. Fevang,et al.  Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency , 2019, Scientific Reports.

[13]  B. Fevang,et al.  Selective IgA deficiency in humans is associated with reduced gut microbial diversity. , 2019, The Journal of allergy and clinical immunology.

[14]  J. de Goede,et al.  Circulating n-3 fatty acids and linoleic acid as indicators of dietary fatty acid intake in post-myocardial infarction patients. , 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[15]  T. Karlsen,et al.  Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency , 2019, Scientific Reports.

[16]  William J. Astle,et al.  Whole genome sequencing of a sporadic primary immunodeficiency cohort , 2018, Nature.

[17]  B. Fevang,et al.  Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications , 2018, Journal of Clinical Immunology.

[18]  S. Lochyński,et al.  Polyunsaturated Fatty Acids and Their Potential Therapeutic Role in Cardiovascular System Disorders—A Review , 2018, Nutrients.

[19]  F. Song,et al.  Omega-6 fats for the primary and secondary prevention of cardiovascular disease. , 2018, The Cochrane database of systematic reviews.

[20]  P. Calder,et al.  Omega-6 fatty acids and inflammation. , 2018, Prostaglandins, leukotrienes, and essential fatty acids.

[21]  Nouf Khalid Hamid.  CVID - Common variable immunodeficiency , 2018 .

[22]  E. Riboli,et al.  High erythrocyte levels of the n-6 polyunsaturated fatty acid linoleic acid are associated with lower risk of subsequent rheumatoid arthritis in a southern European nested case–control study , 2018, Annals of the rheumatic diseases.

[23]  E. Feskens,et al.  Circulating Polyunsaturated Fatty Acids as Biomarkers for Dietary Intake across Subgroups: The CODAM and Hoorn Studies , 2018, Annals of Nutrition and Metabolism.

[24]  D. Mozaffarian,et al.  Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. , 2017, The lancet. Diabetes & endocrinology.

[25]  R. Molinari,et al.  Impact of Omega-3 Fatty Acids on the Gut Microbiota , 2017, International journal of molecular sciences.

[26]  F. Turroni,et al.  Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients , 2017, Scientific Reports.

[27]  M. Laakso,et al.  Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort , 2017, Genome Biology.

[28]  J. Manson,et al.  Association of Specific Dietary Fats With Total and Cause-Specific Mortality. , 2016, JAMA internal medicine.

[29]  F. Bäckhed,et al.  Diet–microbiota interactions as moderators of human metabolism , 2016, Nature.

[30]  D. Mozaffarian,et al.  ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. , 2016, JAMA internal medicine.

[31]  T. Karlsen,et al.  Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation , 2016, Mucosal Immunology.

[32]  G. Grosso,et al.  A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter? , 2015, International journal of food sciences and nutrition.

[33]  P. Calder,et al.  Functional Roles of Fatty Acids and Their Effects on Human Health. , 2015, JPEN. Journal of parenteral and enteral nutrition.

[34]  B. Bjørndal,et al.  A Phospholipid-Protein Complex from Krill with Antioxidative and Immunomodulating Properties Reduced Plasma Triacylglycerol and Hepatic Lipogenesis in Rats , 2015, Marine drugs.

[35]  L. Hooper,et al.  Reduction in saturated fat intake for cardiovascular disease. , 2015, The Cochrane database of systematic reviews.

[36]  W. Willett,et al.  Dietary Linoleic Acid and Risk of Coronary Heart Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies , 2014, Circulation.

[37]  D. Mozaffarian,et al.  Circulating and Dietary Omega‐3 and Omega‐6 Polyunsaturated Fatty Acids and Incidence of CVD in the Multi‐Ethnic Study of Atherosclerosis , 2013, Journal of the American Heart Association.

[38]  Sarah L. Westcott,et al.  Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform , 2013, Applied and Environmental Microbiology.

[39]  P. Calder.  Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? , 2013, British journal of clinical pharmacology.

[40]  A. Viste,et al.  Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat , 2012, Lipids in Health and Disease.

[41]  P. Calder.  Long-chain fatty acids and inflammation , 2012, Proceedings of the Nutrition Society.

[42]  C. Cunningham-Rundles,et al.  Morbidity and mortality in common variable immune deficiency over 4 decades. , 2012, Blood.

[43]  F. Bushman,et al.  Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags , 2010, BMC Microbiology.

[44]  C. Cunningham-Rundles.  How I treat common variable immune deficiency. , 2010, Blood.

[45]  P. Galan,et al.  Plasma n-6 and n-3 polyunsaturated fatty acids as biomarkers of their dietary intakes: a cross-sectional study within a cohort of middle-aged French men and women , 2008, European Journal of Clinical Nutrition.

[46]  B. Fielding,et al.  Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. , 2008, Progress in lipid research.

[47]  K. Fritsche.  Too much linoleic acid promotes inflammation-doesn't it? , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[48]  Lennart Hammarstrom,et al.  Common variable immunodeficiency disorders: division into distinct clinical phenotypes. , 2008, Blood.

[49]  H. Campos,et al.  The use of fatty acid biomarkers to reflect dietary intake , 2006, Current opinion in lipidology.

[50]  P. Calder,et al.  Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. , 2005, Reproduction, nutrition, development.

[51]  L. Andersen,et al.  Evaluation of three dietary assessment methods and serum biomarkers as measures of fruit and vegetable intake, using the method of triads. , 2005, The British journal of nutrition.

[52]  H. Kanegane,et al.  Primary Immunodeficiency Diseases Report of an IUIS Scientific Committee , 1999 .

[53]  L. Andersen,et al.  Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum. , 1999, American journal of epidemiology.

[54]  D. Ahlquist,et al.  A stool collection device: the first step in occult blood testing. , 1988, Annals of internal medicine.

[55]  J. Stockman.  Morbidity and mortality in common variable immune deficiency over 4 decades , 2013 .

[56]  C. Galambos.  Common variable immunodeficiency disorders: division into distinct clinical phenotypes , 2009 .

[57]  Eren,et al.  The EUROclass trial: defining subgroups in common variable immunodeficiency. , 2008, Blood.

[58]  Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. , 1999, Clinical and experimental immunology.